Related Experiment Videos
Brain membrane phospholipid alterations in Alzheimer's disease
J W Pettegrew1, K Panchalingam, R L Hamilton
1Department of Psychiatry. School of Medicine, University of Pittsburgh, Pennsylvania, USA. pettegre@pitt.edu
Neurochemical Research
|September 22, 2001
Summary
Alzheimer's disease (AD) brains show altered phospholipid levels, with significant reductions in phosphatidylethanol-amine and phosphatidylinositol. These changes in brain membrane metabolites may contribute to AD pathology.
Area of Science:
- Neuroscience
- Biochemistry
- Metabolomics
Background:
- Alzheimer's disease (AD) is characterized by neuropathological hallmarks and cognitive decline.
- Alterations in brain membrane phospholipid metabolite levels are observed in AD patients.
Purpose of the Study:
- To investigate specific changes in brain membrane phospholipid metabolites in Alzheimer's disease using 31P nuclear magnetic resonance (NMR).
Main Methods:
- Analysis of Folch extracts from autopsy brain material using 31P NMR spectroscopy.
- Quantification of phospholipid metabolites including phosphatidylethanolamine (PtdEtn), phosphatidylinositol (PtdIns), sphingomyelin (SPH), and others.
Main Results:
- Significant reductions in PtdEtn and PtdIns levels were found in AD brains.
- Elevations in SPH and the plasmalogen derivative of PtdEtn were observed.
- Specific reductions in diphosphatidylglycerol (DPG) and phosphatidic acid (PtdA) were noted in the superior temporal gyrus.
Conclusions:
- The observed phospholipid alterations in AD brains are distinct from general neurodegeneration or gliosis.
- These metabolic changes may impair membrane repair mechanisms, potentially leading to synaptic loss and A beta peptide aggregation in Alzheimer's disease.